{"id":786973,"date":"2023-09-28T19:54:36","date_gmt":"2023-09-28T23:54:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/"},"modified":"2023-09-28T19:54:36","modified_gmt":"2023-09-28T23:54:36","slug":"quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/","title":{"rendered":"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day"},"content":{"rendered":"

<\/p>\n

Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day<\/b><\/p>\n

BILLERICA, Mass.–(BUSINESS WIRE<\/a>)–Quanterix Corporation<\/a> (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will speak on a panel at Goldman Sachs Alzheimer\u2019s Disease Day on Tuesday, October 3, 2023. The panel, Infrastructure considerations: Outlook for blood-based testing, will be held at 12:15 p.m. ET and is accessible to virtual participants by registering here<\/a>. The presentation will be available for viewing following the conference on Quanterix\u2019s website here: ir.quanterix.com<\/a>.<\/p>\n

\nTo learn more about Quanterix, visit www.quanterix.com\/company\/<\/a>.To learn more about Quanterix\u2019s Simoa\u00ae technology, visit: www.quanterix.com\/simoa-technology\/<\/a>.<\/p>\n

About Quanterix<\/b><\/p>\n

\nFrom discovery to diagnostics, Quanterix\u2019s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company\u2019s Simoa\u00aetechnology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Limit of Quantification (LoQ) of conventional analog methods. Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 2,000 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https:\/\/www.quanterix.com<\/a> or follow us on Twitter<\/a> and LinkedIn<\/a>.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230928005095\/en\/<\/a><\/span><\/p>\n

Media:
\n<\/b>
PAN Communications
\n
Maya Nimnicht
\n
510-334-6273
\n
quanterix@pancomm.com<\/a><\/p>\n

Investor Relations:
\n<\/b>
Ed Joyce
\n
610-306-9917
\n
ir@quanterix.com<\/a><\/p>\n

KEYWORDS:<\/b> Massachusetts United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Medical Supplies Biotechnology Health General Health Biometrics Oncology Health Technology Research Infectious Diseases Genetics Science<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will speak on a panel at Goldman Sachs Alzheimer\u2019s Disease Day on Tuesday, October 3, 2023. The panel, Infrastructure considerations: Outlook for blood-based testing, will be held at 12:15 p.m. ET and is accessible to virtual participants by registering here. The presentation will be available for viewing following the conference on Quanterix\u2019s website here: ir.quanterix.com. To learn more about Quanterix, visit www.quanterix.com\/company\/.To learn more about Quanterix\u2019s Simoa\u00ae technology, visit: www.quanterix.com\/simoa-technology\/. About Quanterix From discovery to diagnostics, Quanterix\u2019s ultrasensitive biomarker detection is fueling breakthroughs only made possible through … <\/p>\n

Continue reading “Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-786973","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nQuanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will speak on a panel at Goldman Sachs Alzheimer\u2019s Disease Day on Tuesday, October 3, 2023. The panel, Infrastructure considerations: Outlook for blood-based testing, will be held at 12:15 p.m. ET and is accessible to virtual participants by registering here. The presentation will be available for viewing following the conference on Quanterix\u2019s website here: ir.quanterix.com. To learn more about Quanterix, visit www.quanterix.com\/company\/.To learn more about Quanterix\u2019s Simoa\u00ae technology, visit: www.quanterix.com\/simoa-technology\/. About Quanterix From discovery to diagnostics, Quanterix\u2019s ultrasensitive biomarker detection is fueling breakthroughs only made possible through … Continue reading "Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-28T23:54:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230928005095r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day\",\"datePublished\":\"2023-09-28T23:54:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\\\/\"},\"wordCount\":317,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230928005095r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\\\/\",\"name\":\"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230928005095r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2023-09-28T23:54:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230928005095r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230928005095r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/","og_locale":"en_US","og_type":"article","og_title":"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day - Market Newsdesk","og_description":"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will speak on a panel at Goldman Sachs Alzheimer\u2019s Disease Day on Tuesday, October 3, 2023. The panel, Infrastructure considerations: Outlook for blood-based testing, will be held at 12:15 p.m. ET and is accessible to virtual participants by registering here. The presentation will be available for viewing following the conference on Quanterix\u2019s website here: ir.quanterix.com. To learn more about Quanterix, visit www.quanterix.com\/company\/.To learn more about Quanterix\u2019s Simoa\u00ae technology, visit: www.quanterix.com\/simoa-technology\/. About Quanterix From discovery to diagnostics, Quanterix\u2019s ultrasensitive biomarker detection is fueling breakthroughs only made possible through … Continue reading \"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-28T23:54:36+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230928005095r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day","datePublished":"2023-09-28T23:54:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/"},"wordCount":317,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230928005095r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/","name":"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230928005095r1&sid=flmnd&distro=nx&lang=en","datePublished":"2023-09-28T23:54:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230928005095r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230928005095r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quanterix-ceo-to-speak-at-goldman-sachs-alzheimers-disease-day\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Quanterix CEO to Speak at Goldman Sachs Alzheimer\u2019s Disease Day"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/786973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=786973"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/786973\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=786973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=786973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=786973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}